Histopathological and immunohistochemical features of proliferative lesions in the pituitary pars distalis of rats

J Toxicol Pathol. 2021 Jan;34(1):1-9. doi: 10.1293/tox.2020-0050. Epub 2020 Sep 12.

Abstract

Pituitary proliferative lesions derived from the endocrine cells of the pars distalis are frequently encountered and adenomas/carcinomas are a common cause of death in standard 2-year carcinogenicity studies using various rat strains, especially Sprague-Dawley. This report describes the immunohistochemical characteristics of pituitary tumors derived from the pars distalis in rats. Prolactin (PRL)-containing tumors are the most common, with PRL/growth hormone (GH) dual positive tumor masses (PRL/GH co-positive tumor masses) being more prevalent than only PRL-positive tumor masses (PRL single-positive tumor masses). GH-containing tumors are relatively numerous and many of these are also PRL/GH co-positive tumor masses. TSH-containing tumors are common in females. PRL-containing tumors have been shown to increase the incidence of hyperlactation in males and mammary adenomas/adenocarcinomas in females, suggesting that these masses are functional tumors.

Keywords: adenoma; carcinoma; focal hyperplasia; pars distalis; pituitary; rat.

Publication types

  • Review